New retinal imaging device in use at Weill Cornell Medical College

Marlborough, MA-The full commercial release and installation of a new retinal imaging device (P200MA, Optos) has been announced at the Weill Cornell Medical College, Department of Ophthalmology, New York.

The new device is an imaging platform for use with the optomap fa angiography procedure. The injection of fluorescein in patients allows the physician to capture ultra-wide-field images of fluorescent blood vessels of the patient's retina in real time.

"Clinically, we expect our new device to be very useful in the diagnosis and management of a number of pole to peripheral pathologies, and particularly diabetes by enabling doctors to carry out highly targeted partial pan-retinal photocoagulation-this will allow for new treatment paradigms and improved patient outcomes," said Thomas W. Butts, chief executive officer. "We are very pleased to deliver this device to retinal specialists as it opens new global market segments for us within the medical care segment, of which we estimate a target opportunity of approximately 2.7 million procedures annually in our existing markets in North America and Europe."